KADCYLA® (ado-trastuzumab emtansine) Preparation & Storage in EBC
Familiarize yourself with KADCYLA® (ado-trastuzumab emtansine) preparation and storage in HER2+ early breast cancer. See Full Safety and Boxed Warnings for more information.
Frontiers Ado-tratuzumab emtansine beyond breast cancer
WO2015164665A1 - Methods of treating early breast cancer with
Antibody-Drug Conjugates (ADCs) in Oncology- Competitive Landscape
KADCYLA- ado-trastuzumab emtansine injection, powder, lyophilized
Kadcyla: a new option in locally advanced or metastatic breast cancer
Clinical Trial Results in EBC KADCYLA® (ado-trastuzumab emtansine)
Kadcyla Full Prescribing Information, Dosage & Side Effects
Kadcyla: Package Insert
Clinical Trial Information for KADCYLA® (ado-trastuzumab emtansine
What is KADCYLA® (ado-trastuzumab emtansine) for EBC?
Dosing & Administration PHESGO® (pertuzumab / trastuzumab
How KADCYLA® (ado-trastuzumab emtansine) is Designed to Work in MBC
Kadcyla 100 mg Powder for Concentrate for Solution for Infusion